LENZ Therapeutics Inc (LENZ)
34.00
-2.39
(-6.57%)
USD |
NASDAQ |
Nov 14, 16:00
35.62
+1.62
(+4.76%)
After-Hours: 18:13
LENZ Therapeutics Enterprise Value: 783.65M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 783.65M |
| November 12, 2024 | 807.30M |
| November 11, 2024 | 766.05M |
| November 08, 2024 | 747.35M |
| November 07, 2024 | 677.50M |
| November 06, 2024 | 669.25M |
| November 05, 2024 | 570.79M |
| November 04, 2024 | 564.74M |
| November 01, 2024 | 550.99M |
| October 31, 2024 | 524.32M |
| October 30, 2024 | 542.46M |
| October 29, 2024 | 558.12M |
| October 28, 2024 | 566.09M |
| October 25, 2024 | 525.42M |
| October 24, 2024 | 470.46M |
| October 23, 2024 | 478.15M |
| October 22, 2024 | 460.84M |
| October 21, 2024 | 530.09M |
| October 18, 2024 | 552.08M |
| October 17, 2024 | 506.18M |
| October 16, 2024 | 531.74M |
| October 15, 2024 | 503.71M |
| October 14, 2024 | 483.65M |
| October 11, 2024 | 461.94M |
| October 10, 2024 | 431.44M |
| Date | Value |
|---|---|
| October 09, 2024 | 454.79M |
| October 08, 2024 | 453.69M |
| October 07, 2024 | 441.88M |
| October 04, 2024 | 491.34M |
| October 03, 2024 | 400.66M |
| October 02, 2024 | 411.92M |
| October 01, 2024 | 409.45M |
| September 30, 2024 | 435.28M |
| September 27, 2024 | 464.91M |
| September 26, 2024 | 415.69M |
| September 25, 2024 | 396.99M |
| September 24, 2024 | 400.29M |
| September 23, 2024 | 396.17M |
| September 20, 2024 | 419.54M |
| September 19, 2024 | 411.02M |
| September 18, 2024 | 395.07M |
| September 17, 2024 | 384.07M |
| September 16, 2024 | 378.84M |
| September 13, 2024 | 404.97M |
| September 12, 2024 | 371.69M |
| September 11, 2024 | 384.62M |
| September 10, 2024 | 462.16M |
| September 09, 2024 | 469.03M |
| September 06, 2024 | 458.31M |
| September 05, 2024 | 460.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
161.57M
Minimum
Jun 04 2024
807.30M
Maximum
Nov 12 2024
366.73M
Average
393.61M
Median
Enterprise Value Benchmarks
| Oruka Therapeutics Inc | -- |
| TruBridge Inc | 408.40M |
| PetMed Express Inc | 56.96M |
| Streamline Health Solutions Inc | 18.98M |
| R1 RCM Inc | 8.078B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.22M |
| Total Expenses (Quarterly) | 12.94M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | -15.41% |